Excellent post SF, and in line with my own expectations. $2.46 price target is not unrealistic and a great return for long term holders. $570 millions seems an achievable and not unreasonable takeover price for a buyer and shareholders too.
Mr D holds.
- Forums
- ASX - By Stock
- BOW
- price per gigajoule
price per gigajoule, page-3
Featured News
Add BOW (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online